Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> DIABETES Latest News

FEB 01, 2013 - Yahoo! News

A Must Read - Share

Merck beats forecast, but issues cautious 2013 view

(Reuters) - Merck & Co's quarterly results beat forecasts, helped by strong sales of its Januvia diabetes drug and Gardasil vaccine against cervical cancer, but the company issued a full-year 2013 profit view at the low end of Wall Street expectations The No. 2 U.S. drugmaker on Friday said it earned $1.4 billion, or 46 cents per share, in the fourth quarter. That compared with $1.51 billion, or 49 cents per share, in the year-earlier period, when the company took charges for acquisition and restructuring expenses. Excluding special items, Merck earned 83 cents per share. ...

Tags: Merck beats forecast, but issues cautious 2013 view,  Diabetes Latest News